Investors Capital Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Investors Capital Advisory Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.32M	Sell	20,857 -1,702	-8%	-$107K	0.25%	98
2016 Q1	$1.35M	Sell	22,559 -2,607	-10%	-$159K	0.27%	89
2015 Q4	$1.76M	Buy	25,166 +239	+1%	+$16.9K	0.34%	60
2015 Q3	$1.65M	Sell	24,927 -171	-0.7%	-$13.3K	0.33%	60
2015 Q2	$1.97M	Buy	25,098 +643	+3%	+$50.1K	0.36%	53
2015 Q1	$1.87M	Buy	24,455 +3,094	+14%	+$227K	0.35%	55
2014 Q4	$1.42M	Sell	21,361 -777	-4%	-$51.7K	0.27%	90
2014 Q3	$1.41M	Buy	22,138 +839	+4%	+$51.8K	0.28%	86
2014 Q2	$1.3M	Buy	21,299 +588	+3%	+$34.1K	0.21%	135
2014 Q1	$1.17M	Buy	20,711 +225	+1%	+$12.8K	0.25%	104
2013 Q4	$1.09M	Buy	20,486 +3,435	+20%	+$172K	0.25%	113
2013 Q3	$784K	Buy	17,051 +2,615	+18%	+$119K	0.2%	139
2013 Q2	$610K	Buy	+14,436	New	+$601K	0.19%	156

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

MWM

Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return

Investors Capital Advisory Services's PJP Position: Q2 2016 in Review

Investors Capital Advisory Services reduced its Invesco Pharmaceuticals ETF (PJP) stake by 7.5% in Q2 2016, selling an estimated $107K and leaving 20,857 shares worth $1.32M. The position accounts for 0.25% of the portfolio, ranked #98.

Investors Capital Advisory Services first reported a position in PJP in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.97M in Q2 2015. 97 funds tracked by Wall St. Rank hold PJP as of Q2 2016.

Investors Capital Advisory Services held 20,857 shares of Invesco Pharmaceuticals ETF worth $1.32M as of Q2 2016.
Investors Capital Advisory Services sold 1,702 Invesco Pharmaceuticals ETF shares in Q2 2016, an estimated $107K.
Invesco Pharmaceuticals ETF made up 0.25% of Investors Capital Advisory Services's portfolio in Q2 2016, its #98 holding.
Investors Capital Advisory Services first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 13 quarters since.
Investors Capital Advisory Services's Invesco Pharmaceuticals ETF position peaked at $1.97M in Q2 2015.
97 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2016.

Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.